Allotment is out. Check your result on the Avience Biomedicals SME IPO Allotment Status page.
Avience Biomedicals SME logo

Avience Biomedicals SME IPO Subscription

Listed

Updated 25 June 2026, 9:15 AM IST· NSE SME

Avience Biomedicals SME IPO subscription closed on 22 June 2026 at 385.40x overall by shares. QIB demand came in at 196.77x, NII at 597.63x, and retail at 401.36x. See Retail, SHNI, and BHNI allotment chances in the…

Show more

Allotment date is 23 June 2026. Listing date on NSE and BSE is 25 June 2026.

Issue Price
Rs 208.00
GMP Today
Rs 145.00 (+69.71%)
Overall Sub
385.40x
Issue Size
₹30.24 Cr
Allotment
23 Jun 2026
Listing
25 Jun 2026

Avience Biomedicals SME IPO Day-wise Subscription

Daily QIB, NII, Retail, and overall subscription as bids come in

DayQIBNIIRetailOverall
Day 1 - 18 Jun 20260.00x13.49x15.69x10.75x
Day 2 - 19 Jun 20260.03x66.36x58.97x43.79x
Day 3 - 22 Jun 2026196.77x597.23x401.21x385.24x

Avience Biomedicals SME IPO Allotment Chances

Retail, SHNI, and BHNI chances based on application subscription

Avience Biomedicals SME IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.

CategorySubscription (Apps)Allotment Chances
Retail (IND)401.36x1 in 401
SHNI (Rs 2L to Rs 10L)403.79x1 in 404
BHNI (above Rs 10L)214.18x1 in 214

Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.

Check the Avience Biomedicals SME IPO Allotment Status page from 23 June 2026 for your result.

Avience Biomedicals SME IPO Subscription by Amount

Category-wise subscription based on amount applied at issue price Rs 208.00

CategoryAmount OfferedAmount AppliedSubscription
QIBRs 5.69 CrRs 1,119.82 Cr196.77x
FII-Rs 195.21 Cr-
DFI-Rs 139.51 Cr-
Mutual Funds-Rs 18.70 Cr-
Other-Rs 766.40 Cr-
NIIRs 4.31 CrRs 2,573.16 Cr597.63x
bNII (above Rs 10L)Rs 2.87 CrRs 1,925.39 Cr670.77x
Corporate-Rs 22.94 Cr-
Individual-Rs 1,888.74 Cr-
Other-Rs 13.72 Cr-
sNII (Rs 2L to Rs 10L)Rs 1.44 CrRs 647.77 Cr451.35x
Corporate-Rs 5.07 Cr-
Individual-Rs 634.26 Cr-
Other-Rs 8.45 Cr-
INDRs 10.01 CrRs 4,017.16 Cr401.36x
TotalRs 20.01 CrRs 7,710.14 Cr385.40x

Avience Biomedicals SME IPO Subscription by Applications

Category-wise subscription based on applications received

CategoryApplications OfferedApplications ReceivedSubscription
QIB4561720.38x
FII-23-
DFI-80-
Mutual Funds-3-
Other-66-
NII11531,836276.83x
bNII (above Rs 10L)7716,492214.18x
Corporate-181-
Individual-16,193-
Other-118-
sNII (Rs 2L to Rs 10L)3815,344403.79x
Corporate-133-
Individual-14,995-
Other-216-
IND4011,60,944401.36x
Total9721,92,952198.51x

What Do These Subscription Numbers Mean?

385.40x overall by shares means bids covered about 385 times the shares on offer. Allotment chances depend on applications in each category.

QIB at 196.77x by shares shows institutional demand from mutual funds, FIIs, and banks.

NII covers bids above Rs 2 lakh (276.83x by applications). Split: SHNI 403.79x, BHNI 214.18x by applications. SHNI and BHNI allotment is by lottery.

At 401.36x subscription by applications, about 1 in 401 retail applicants may get allotment (~1% chance per application). Retail allotment is also by lottery.

Avience Biomedicals SME IPO GMP After Subscription

GMP for Avience Biomedicals SME stands at Rs 145.00 today, giving an estimated listing price of Rs 353.00 per share.

A subscription of 385.40x combined with a GMP of 69.71% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.

Track live GMP on the Avience Biomedicals SME IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.

Avience Biomedicals SME IPO Key Dates

EventDate
IPO Open Date18 June 2026
IPO Close Date22 June 2026
Allotment Date23 June 2026
Refund Initiation24 June 2026
Share Credit to Demat24 June 2026
Listing Date25 June 2026
Minimum InvestmentRs 2,49,600.00
Lot Size600 shares

About Avience Biomedicals SME

Avience Biomedicals Limited, incorporated in June 2024, is an ISO-certified healthcare and biotechnology solutions company. The enterprise specializes in manufacturing, supplying, and exporting high-precision molecular diagnostic formulations, in-vitro diagnostics (IVD) rapid test kits, serology products, and automated biochemistry and hematology analyzers. Operating entirely on business-to-business (B2B) and business-to-government (B2G) frameworks, Avience provides cost-effective diagnostics to premier hospital networks, pathology labs, and research institutions.

Understanding Subscription Categories

QIB - Qualified Institutional Buyers

Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.

NII - Non-Institutional Investors (SHNI & BHNI)

Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.

IND - Individual Investors

Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.

Advertisement

Avience Biomedicals SME IPO Subscription FAQs

What is Avience Biomedicals SME IPO subscription status today?

Avience Biomedicals SME IPO subscription closed on 22 June 2026 with overall subscription of 385.40x (by shares) as of 18 October 2026, 5:17 PM IST. QIB 196.77x, NII 276.83x, IND 401.36x.

What is the overall subscription of Avience Biomedicals SME IPO?

Avience Biomedicals SME IPO is subscribed 385.40x overall by shares at close on 22 June 2026. QIB 196.77x, NII 276.83x, and IND 401.36x.

What is Avience Biomedicals SME IPO QIB subscription?

Avience Biomedicals SME IPO QIB (Qualified Institutional Buyers) subscription is 196.77x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.

What is Avience Biomedicals SME IPO IND subscription?

Avience Biomedicals SME IPO IND subscription is 401.36x by applications. Retail bids are up to Rs 2 lakh per PAN.

What is Avience Biomedicals SME IPO NII, SHNI, and BHNI subscription?

Avience Biomedicals SME IPO NII subscription is 276.83x by applications. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) at 403.79x and BHNI (above Rs 10L) at 214.18x.

What are Avience Biomedicals SME IPO retail allotment chances?

At 401.36x subscription by applications, about 1 in 401 retail applicants may get allotment (~1% chance per application). Allotment is by lottery.

What are Avience Biomedicals SME IPO SHNI allotment chances?

At 403.79x subscription by applications, about 1 in 404 SHNI applicants may get allotment (~1% chance per application). Allotment is by lottery. Share subscription was 451.35x. Allotment chances use applications, not share volume.

What are Avience Biomedicals SME IPO BHNI allotment chances?

At 214.18x subscription by applications, about 1 in 214 BHNI applicants may get allotment (~1% chance per application). Allotment is by lottery. Share subscription was 670.77x. Allotment chances use applications, not share volume.

When is Avience Biomedicals SME IPO allotment date?

Avience Biomedicals SME IPO allotment date is 23 June 2026. Check Avience Biomedicals SME IPO Allotment Status on IPOwiz from that day using your PAN.

When does Avience Biomedicals SME IPO subscription close?

Avience Biomedicals SME IPO subscription closed on 22 June 2026. No new applications are accepted after the close.

What is Avience Biomedicals SME IPO GMP today?

Avience Biomedicals SME IPO GMP is ₹145 today (+69.71% over issue price ₹208). See live GMP on the Avience Biomedicals SME IPO GMP Today page.

What is Avience Biomedicals SME IPO issue price and lot size?

Avience Biomedicals SME IPO issue price is ₹208 per share. Lot size is 600 shares. Minimum investment is ₹2,49,600 per lot (minimum 2 lots for SME). Issue size: ₹30.24 Cr.

When is Avience Biomedicals SME IPO listing date?

Avience Biomedicals SME IPO listing date is 25 June 2026 on NSE and BSE. Allotment is on 23 June 2026.

How does subscription affect Avience Biomedicals SME IPO allotment?

In Avience Biomedicals SME IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 385.40x overall, competition is very high.

For allotment results from 23 June 2026, visit the Avience Biomedicals SME IPO Allotment Status page. For listing day updates on 25 June 2026, download the IPOwiz App.

Sources

We match Avience Biomedicals SME IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • IPO RegistrarRegistrar details are on the allotment page for this IPO

Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.